TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A Northwestern-led study reports that a specific site on tau proteins helps misfolded tau recruit and align other tau molecules into growing fibrils. In experiments, chemically blocking that site stopped fibril growth, but the findings do not establish a treatment or show that blocking the hotspot prevents dementia in people.
A Northwestern University-led study has identified a hotspot on tau proteins that appears to help misfolded tau recruit and align other tau molecules into growing fibrils, a process associated with several forms of dementia. The researchers report that chemically blocking the hotspot stopped fibril growth in their experiments, suggesting a possible target for future research, not a proven treatment for patients.
The study, conducted with researchers at the University of California, Santa Barbara, examined how tau molecules that have misfolded can prompt other tau molecules to adopt the same shape. Tau proteins normally lack a fixed structure, the report explains, but misfolded molecules can stack into long fibrils. The researchers focused on how incoming tau finds the correct position at a fibril’s growing end.
According to the study summary, the team found a dominant hotspot on aggregation-prone tau. It can bind to a matching site on another tau molecule or at the end of an existing fibril, helping the incoming molecule misfold and line up with the others. The researchers describe this alignment as necessary for fibrils to keep growing in the same arrangement.
The hotspot lies in a hydrophobic region, which tends to repel water. The team reports that water molecules form a dynamic cap around the site. When two matching hotspots meet, that water is released, helping the tau molecules bind. In experiments, adding a chemical tag to the hotspot stopped fibril growth; tagging two other sites away from it did not have the same effect, according to the report.
A Possible Target on Tau Fibrils
The findings offer a more specific account of one step in tau aggregation: how misfolded tau may recruit more tau and maintain a consistent structure as a fibril grows. That matters because tau fibrils can accumulate inside neurons as neurofibrillary tangles, which are associated with disruption of communication between nerve cells.
Identifying a site that appears to be necessary for fibril growth could help researchers design experiments to interrupt that process. The study’s authors also suggest the hotspot may inform future diagnostic tools, therapeutic research and laboratory models that reproduce different tau-related diseases. Those are potential applications, however; the reported experiments do not show that a drug targeting the site can slow disease, improve symptoms or prevent tau from spreading in the human brain.
Songi Han, the study’s senior author and a chemistry professor at Northwestern, said the work may give drug researchers a more focused place to investigate. “Once you know that aggregation-prone tau proteins always have a hotspot that is first attracted to the same site of tau that is stacked to fibrils, then you know there’s always some part of the protein that you can target to neutralize,” Han said in the report. The statement describes a research direction rather than a clinical result.
As an affiliate, we earn on qualifying purchases.
How Tau Forms Growing Fibrils
Alzheimer’s disease and frontotemporal dementia are among the conditions described as tauopathies, in which tau misfolding and buildup are linked to neurological decline. Tau’s unstructured form has made it challenging to explain how individual molecules repeatedly find the same alignment and form fibrils.
In the account provided by News-Medical, tau fibrils grow as misfolded molecules stack in register, with each new molecule adopting a shape that matches the one beneath it. Han said even a small alignment mismatch could eventually stop a fibril from growing. The proposed hotspot-and-water-cap mechanism offers an explanation for how matching tau molecules may connect in a consistent way.
The study is scheduled to appear in the Proceedings of the National Academy of Sciences on October 16, 2026. The supplied report does not give the study’s title, full methods, sample sizes or a detailed account of the experimental systems, so those details cannot be assessed from the available material.
““If you know where to block its action of misfolding, you could block it to prevent it from propagating.””
— Songi Han, senior author and Northwestern University chemistry professor
From Laboratory Finding to Treatment
The findings described in the report concern experiments on tau fibril growth. The available source material does not establish that the same hotspot mechanism operates identically in living people, or that blocking it would prevent tau-related damage in the brain. It also provides no evidence of a tested medicine, clinical trial or patient benefit.
The precise experimental methods, the number and type of samples, and whether the mechanism varies across different tauopathies are not detailed in the supplied account. It is also unclear how researchers might reach the hotspot safely and selectively in the brain. The study’s publication is scheduled for October 16, and its full paper may provide further information about the evidence and its limits.
Publication and Follow-Up Research
The study is due to publish in the Proceedings of the National Academy of Sciences on October 16, 2026. The full paper will be needed to examine the methods, results and scope of the experiments beyond the summary reported by News-Medical.
Next steps suggested by the researchers include testing ways to block the hotspot, exploring whether it can support diagnostic or therapeutic research, and developing synthetic tau fibrils that reproduce disease-related structures. Those are research possibilities, not announced clinical plans. Any claim that the discovery can lead to a treatment will depend on further laboratory work and, if a candidate intervention is developed, testing for safety and effectiveness.
Key Questions
What did the researchers identify?
They reported a hotspot on aggregation-prone tau that can bind to a matching site on another tau molecule or at the end of a fibril, helping tau align as the fibril grows.
How does water relate to the hotspot?
The researchers say water forms a dynamic cap around the hotspot in tau’s hydrophobic region. When matching sites meet, the water is released, helping the proteins bind.
Does the study show that dementia can be treated or prevented?
No. The report describes experiments on tau fibril growth and a result from chemically tagging the hotspot. It does not show a treatment effect in people or establish that blocking the site prevents dementia.
When will the study be published?
The study is scheduled to appear in the Proceedings of the National Academy of Sciences on October 16, 2026, according to the source report.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
